ES492664A0 - Un procedimiento para la preparacion de un muramildipeptido. - Google Patents
Un procedimiento para la preparacion de un muramildipeptido.Info
- Publication number
- ES492664A0 ES492664A0 ES492664A ES492664A ES492664A0 ES 492664 A0 ES492664 A0 ES 492664A0 ES 492664 A ES492664 A ES 492664A ES 492664 A ES492664 A ES 492664A ES 492664 A0 ES492664 A0 ES 492664A0
- Authority
- ES
- Spain
- Prior art keywords
- group
- carbon atoms
- image
- acyl
- muramildipeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000004432 carbon atom Chemical group C* 0.000 abstract 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 abstract 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 abstract 2
- 125000002252 acyl group Chemical group 0.000 abstract 2
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 abstract 1
- 239000004471 Glycine Substances 0.000 abstract 1
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 abstract 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 abstract 1
- 239000002671 adjuvant Substances 0.000 abstract 1
- 229960003767 alanine Drugs 0.000 abstract 1
- 150000007933 aliphatic carboxylic acids Chemical class 0.000 abstract 1
- 125000001931 aliphatic group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000000539 amino acid group Chemical group 0.000 abstract 1
- 125000005392 carboxamide group Chemical group NC(=O)* 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 229960002449 glycine Drugs 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000000813 microbial effect Effects 0.000 abstract 1
- BSOQXXWZTUDTEL-ZUYCGGNHSA-N muramyl dipeptide Chemical class OC(=O)CC[C@H](C(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)O[C@@H](O)[C@@H]1NC(C)=O BSOQXXWZTUDTEL-ZUYCGGNHSA-N 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 229960001153 serine Drugs 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 229960004295 valine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
- C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
- C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7831779A JPS5618996A (en) | 1979-06-21 | 1979-06-21 | Muramyldipeptide derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
ES8200645A1 ES8200645A1 (es) | 1981-11-16 |
ES492664A0 true ES492664A0 (es) | 1981-11-16 |
Family
ID=13658554
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES492664A Granted ES492664A0 (es) | 1979-06-21 | 1980-06-20 | Un procedimiento para la preparacion de un muramildipeptido. |
Country Status (11)
Country | Link |
---|---|
US (1) | US4317771A (en]) |
EP (1) | EP0021367B1 (en]) |
JP (1) | JPS5618996A (en]) |
AT (1) | ATE2958T1 (en]) |
AU (1) | AU534233B2 (en]) |
CA (1) | CA1183128A (en]) |
DE (1) | DE3062609D1 (en]) |
ES (1) | ES492664A0 (en]) |
PH (1) | PH15892A (en]) |
SU (1) | SU1190990A3 (en]) |
ZA (1) | ZA803483B (en]) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2482959A2 (fr) * | 1979-06-29 | 1981-11-27 | Rhone Poulenc Ind | Nouveaux tripeptides, leur preparation et les medicaments qui les contiennent |
GR78246B (en]) * | 1981-01-23 | 1984-09-26 | Ciba Geigy Ag | |
US4522811A (en) * | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
JPS5920297A (ja) * | 1982-07-27 | 1984-02-01 | Dai Ichi Seiyaku Co Ltd | ムラミルジペプチド誘導体 |
JPS59172497A (ja) * | 1983-03-22 | 1984-09-29 | Dai Ichi Seiyaku Co Ltd | 新規ムラミルペプチド誘導体 |
FR2546756B1 (fr) * | 1983-06-03 | 1985-11-29 | Centre Nat Rech Scient | Nouveaux derives immunostimulants, leur preparation et leur application comme medicament |
US4474693A (en) * | 1983-10-31 | 1984-10-02 | E. R. Squibb & Sons, Inc. | ACE inhibitors produced from Nocardia orientalis |
JPS6157597A (ja) * | 1984-08-29 | 1986-03-24 | Toshiyuki Hamaoka | ムラミルペプチド活性エステル誘導体 |
JPS6393724A (ja) * | 1986-10-09 | 1988-04-25 | Dai Ichi Seiyaku Co Ltd | ムラミルジペプチド誘導体含有鎮痛消炎剤 |
US4950645A (en) * | 1988-07-08 | 1990-08-21 | Immunotherapeutics, Inc. | Composition for macrophage activation |
US5416070A (en) * | 1988-07-08 | 1995-05-16 | Immunotherapeutics, Inc. | Composition for macrophage activation |
GB9320820D0 (en) * | 1993-10-08 | 1993-12-01 | Biokine Tech Ltd | Compounds for medicinal use |
CN100522995C (zh) * | 2003-10-22 | 2009-08-05 | 中国医学科学院药物研究所 | 胞壁酰-丙氨酰-d-异谷氨酰胺衍生物、制法和其药物组合物与用途 |
US9688718B2 (en) | 2008-01-11 | 2017-06-27 | Lawrence Livermore National Security, Llc | Nanolipoprotein particles comprising hydrogenases and related products, methods and systems |
US8883729B2 (en) * | 2008-05-22 | 2014-11-11 | Lawrence Livermore National Security, Llc | Nanolipoprotein particles and related compositions, methods and systems |
US9303273B2 (en) | 2008-05-09 | 2016-04-05 | Lawrence Livermore National Security, Llc | Nanolipoprotein particles comprising a natural rubber biosynthetic enzyme complex and related products, methods and systems |
EP3239139B1 (en) | 2010-05-27 | 2020-10-28 | Ningbo Combireg Pharmaceutical Technology Co. Ltd | Chemical synthesis and anti-tumor and anti-metastatic effects of dual functional conjugate |
CN102219834A (zh) * | 2011-04-14 | 2011-10-19 | 北京市丰硕维康技术开发有限责任公司 | 一种制备罗莫肽的方法 |
US9644038B2 (en) | 2011-12-21 | 2017-05-09 | The Regents Of The University Of California | Apolipoprotein nanodiscs with telodendrimer |
WO2016049061A1 (en) | 2014-09-22 | 2016-03-31 | Lawrence Livermore National Security, Llc | Electrochemical flow-cell for hydrogen production and nicotinamide co-factor dependent target reduction, and related methods and systems |
WO2016138286A1 (en) | 2015-02-26 | 2016-09-01 | Stc.Unm | Irgm and precision autophagy controls for antimicrobial and inflammatory disease states and methods of detection of autophagy |
US12226529B2 (en) | 2015-08-25 | 2025-02-18 | Lawrence Livermore National Security, Llc | Stable nanolipoprotein particles and related compositions methods and systems |
WO2017044899A1 (en) | 2015-09-11 | 2017-03-16 | Lawrence Livermore National Security, Llc | Synthetic apolipoproteins, and related compositions methods and systems for nanolipoprotein particles formation |
DK3448364T3 (da) | 2016-04-29 | 2022-05-02 | Icahn School Med Mount Sinai | Målretning af det iboende immunsystem med henblik på at frembringe langvarig tolerance og at opløse akkumulering af makrofager ved aterosklerose |
US12083223B2 (en) | 2017-05-02 | 2024-09-10 | Lawrence Livermore National Security, Llc | Nanolipoprotein particles and related compositions methods and systems for loading RNA |
WO2018204421A2 (en) | 2017-05-02 | 2018-11-08 | Lawrence Livermore National Security, Llc | Momp telonanoparticles, and related compositions, methods and systems |
EP4308105A4 (en) | 2021-03-19 | 2025-03-12 | Trained Therapeutix Discovery, Inc. | COMPOUNDS FOR REGULATING TRAINED IMMUNITY, AND METHODS OF USE THEREOF |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH613709A5 (en) * | 1975-12-10 | 1979-10-15 | Ciba Geigy Ag | Process for the preparation of glucosamine derivatives |
FR2358159A1 (fr) * | 1976-07-16 | 1978-02-10 | Anvar | Le diamide de l'acide 2-(2-acetamido-2-deoxy-3 - o-d-glucopyranosyl) - d-propionyl-l-alanyl-d-glutamique et medicaments le contenant |
CA1138436A (en) * | 1978-02-24 | 1982-12-28 | Gerhard Baschang | Process for the manufacture of novel antigens |
FR2442241A2 (fr) * | 1978-03-20 | 1980-06-20 | Anvar | Nouveaux composes esters de muramyl-peptide, leur preparation et les compositions pharmaceutiques les contenant, notamment sous forme de liposomes |
FR2428050A1 (fr) * | 1978-06-05 | 1980-01-04 | Anvar | Oligomeres de composes du type muramyl-peptide et medicaments les contenant |
US4256735A (en) * | 1979-01-29 | 1981-03-17 | Merck & Co., Inc. | Immunologically active dipeptidyl saccharides and methods of preparation |
-
1979
- 1979-06-21 JP JP7831779A patent/JPS5618996A/ja active Granted
-
1980
- 1980-06-06 AU AU59101/80A patent/AU534233B2/en not_active Expired
- 1980-06-11 ZA ZA00803483A patent/ZA803483B/xx unknown
- 1980-06-13 CA CA000354017A patent/CA1183128A/en not_active Expired
- 1980-06-18 PH PH24162A patent/PH15892A/en unknown
- 1980-06-20 DE DE8080103461T patent/DE3062609D1/de not_active Expired
- 1980-06-20 ES ES492664A patent/ES492664A0/es active Granted
- 1980-06-20 EP EP80103461A patent/EP0021367B1/en not_active Expired
- 1980-06-20 SU SU802936451A patent/SU1190990A3/ru active
- 1980-06-20 AT AT80103461T patent/ATE2958T1/de not_active IP Right Cessation
- 1980-06-23 US US06/162,233 patent/US4317771A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US4317771A (en) | 1982-03-02 |
JPS6227079B2 (en]) | 1987-06-12 |
AU534233B2 (en) | 1984-01-12 |
DE3062609D1 (en) | 1983-05-11 |
CA1183128A (en) | 1985-02-26 |
ATE2958T1 (de) | 1983-04-15 |
ZA803483B (en) | 1981-06-24 |
PH15892A (en) | 1983-04-14 |
JPS5618996A (en) | 1981-02-23 |
ES8200645A1 (es) | 1981-11-16 |
EP0021367A1 (en) | 1981-01-07 |
SU1190990A3 (ru) | 1985-11-07 |
EP0021367B1 (en) | 1983-04-06 |
AU5910180A (en) | 1981-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES492664A0 (es) | Un procedimiento para la preparacion de un muramildipeptido. | |
DK116480A (da) | Fremgangsmaade til fremstilling af substituerede chromoner | |
ES545842A0 (es) | Procedimiento para preparar difosfonatos | |
DE3270583D1 (en) | Inhibitors of mammalian collagenase | |
IE801251L (en) | Inhibitors of mammalian collagenase | |
PL315689A1 (en) | Substituted 3-arylideno-7-azaoxindole compounds and method of obtaining them | |
SE9100342D0 (sv) | Novel steroid esters | |
ES488788A0 (es) | Procedimiento de preparacion de una composicion farmaceuticaen particular psicotropa. | |
ES505672A0 (es) | Procedimiento para la preparacion de oximas de acidos piru- vicos | |
SE8604950D0 (sv) | Dementia-improving and therapeutic agents | |
ES493301A0 (es) | Procedimiento para la preparacion de bis-amidas de acidos 5-amino-2,4,6-triyodo-isoftalicos | |
ES2076623T3 (es) | 3,4-dihidro-naftalinas sustituidas, su procedimiento de preparacion y medicamentos que las contienen. | |
RS50423B (sr) | Novi derivati oktahidro-6,10-diokso-6h-piridazino(1,2-a) (1,2) diazepin-1-karboksilne kiseline, njihov postupak dobijanja i njihova primena za dobijanje farmaceutski aktivnih jedinjenja | |
SE8206981D0 (sv) | N-(vinblastinoyl-23) derivatives of amino acids, their preparation and therapeutical application | |
GEP19970937B (en) | Method of producing derivatives of muramyldipeptide | |
EP0331756A4 (en) | Agents for prophylaxis and treatment of thrombopenia | |
ES453997A1 (es) | Procedimiento para la preparacion de acetatos de eteraminas secundarias. | |
ES8300686A1 (es) | Un procedimiento para la produccion de una amida de un d-aminoacido. | |
DK128892A (da) | Benzyletherderivater | |
SE7714525L (sv) | Sett att framstella n-substituerade 2-aminocyklopent-1-en-1-ditiokarboxylsyror | |
SE7714526L (sv) | Sett att framstella 2-amino-cyklopent-1-en-1-tiokarbonyl-disulfider | |
KR950008518A (ko) | 신규한 세팔로스포린계 항생제 및 이의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC1A | Transfer granted |